A new low is a new low is a new low. However, on low volume. Hard to tell where it goes, certainly no massive influx of buyers. Better places for me to put my cash to work where the share price is supported by cash in the bank as well as positive earnings, solid book values near where share prices sit. Those I can usually rely on.
Noticed that Claritin sales impacted by generic competition. Affect on Allegra?